Summary: Join Drs. Eckel, Ridker, and Cannon for a panel discussion on the relationship among LDL-C, low HDL-C, and therapies in development targeting residual CV risk.
Summary: Join Drs. Eckel, Ridker, and Cannon for a panel discussion on the relationship among LDL-C, low HDL-C, and therapies in development targeting residual CV risk.